Skip to content
Open access

Analysis of Potential Antidiabetic Drug Interactions in Patients with Type 2 Diabetes Mellitus Hospitalized at Bandar Lampung X Hospital

Oct 2026 · JURNAL FARMASIMED (JFM) · 0 citations

Abstract

Background: Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia. Hospitalized patients with type 2 diabetes mellitus commonly have comorbidities requiring the concomitant use of multiple medications, which increases the risk of drug interactions that may affect therapeutic effectiveness and increase adverse effects. Objective: This study aimed to determine the potential drug interactions of antidiabetic medications among hospitalized patients with type 2 diabetes mellitus at Hospital X Bandar Lampung in 2025. Methods: This study used a non-experimental method with a retrospective descriptive design. Data were obtained from medical records for the period of January–August 2025. The study population consisted of 612 patients, with a sample of 242 patients selected using systematic random sampling. Potential drug interactions were identified using Medscape and Drugs.com. Results and Discussion: The results show that 169 patients (69.8%) have potential drug interactions, while 73 patients (30.2%) have no potential interactions. A total of 428 potential drug interaction events are identified, consisting of 351 pharmacodynamic interactions (82%) and 77 pharmacokinetic interactions (18%). Based on severity, moderate interactions account for 334 events (78%), while minor interactions account for 94 events (22%). The most frequently identified interaction is between aspirin and insulin glargine, with 20 events (4.7%). Conclusion: This study shows that the potential for drug interactions among hospitalized patients with type 2 diabetes mellitus remains considerable, indicating the need for medication therapy monitoring to improve the safety and effectiveness of treatment.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.